Lingdao Capital
Nanjinglindenasset.com
Overview
Lingdao Capital is a venture capital firm founded in 2018 that focuses on investing in the frontier of China's biomedical field.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BrioHealth Solutions | Jan 2022 | Series D Extension | Co-investor |
| TechnoDerma Medicines Inc. | Apr 2021 | Series A | Co-investor |
| Shanghai Hanyu Medical Technology | Mar 2021 | Series D Extension | Co-investor |
| Singlera Genomics Inc. | Dec 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
